Head-to-head · WeighScore
AZ Health vs Boston Medical Group
The verdict
AZ Health takes it — 69/100 to 61.9/100.
AZ Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AZ Health (AZHM) is an Arizona-based, 100% virtual medical weight-loss clinic offering physician-prescribed compounded semaglutide (from $179/mo) and tirzepatide (from $199/mo), plus NAD+ injections, on…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | AZ Health | Boston Medical Group |
|---|---|---|
| WeighScore | 69/100 | 61.9/100 |
| Grade | C | C |
| Scorecard rank | #133 | #279 |
| Semaglutide | $179/mo (all doses, compounded) | $199/mo (starting strength, rising with dose, compounded) |
| Tirzepatide | $199/mo (all doses, compounded) | Not disclosed |
| Coverage | Coverage not published | 7 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #133 · C
Strengths
- Transparent flat monthly pricing — semaglutide from $179/mo, tirzepatide from $199/mo, no insurance required
- Discloses that compounded medications are not FDA-approved and require a prescription
- FSA/HSA eligible, free discreet shipping, and cancel anytime
- Ongoing physician check-ins; also offers NAD+ injections
Where it loses points
- LegitScript certification is self-stated on the site and not independently verifiable
- Single-page site with no published Terms, Privacy, or HIPAA policy
- Compounding pharmacy partner not named (states only 'FDA-registered pharmacies')
- Legal entity not disclosed; availability limited (~half of US states, Arizona-focused)
Graded #279 · C
Strengths
- An established medical group with a defined 12-week programme rather than an open-ended subscription
- The price range and the 12-week total are both published, once you reach the costs page
- Semaglutide is prescribed and dispensed under a compounded pathway with clinician oversight
Where it loses points
- The published rate is a range by dose strength, $199 to $299, so the figure quoted is the floor rather than what a titrated patient pays
- The 12-week programme totals $699 including a telemedicine platform fee that is never itemised — about $233/mo all-in, not $199
- The weight-loss landing page carries no price at all; the numbers are two pages deeper, in the FAQ and the costs page
- Semaglutide and tirzepatide are not priced separately — one range covers the whole programme
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.